Literature DB >> 25650684

The association between working alliance and clinical and functional outcome in a cohort of 400 patients with first-episode psychosis: a cross-sectional study.

Marianne Melau1, Susanne Harder, Pia Jeppesen, Carsten Hjorthøj, Jens R M Jepsen, Anne Thorup, Merete Nordentoft.   

Abstract

OBJECTIVE: Working alliance between patients with a first-episode psychosis and their case manager is regarded as a key element in specialized early intervention services. The impact of this patient-case manager dyad on functional and clinical outcome is unknown. We aimed to investigate if a strong working alliance was associated with fewer clinical symptoms and better social functioning.
METHOD: In a cross-sectional design, patients with first-episode schizophrenia spectrum disorders (ICD-10, F20-29) were included after 18 months of treatment (N = 400). Baseline data were collected between June 2009 and December 2011. Symptoms were assessed using Scale for the Assessment of Positive Symptoms (SAPS), Scale for the Assessment of Negative Symptoms (SANS), Global Assessment of Functioning (GAF), Brief Assessment of Cognition in Schizophrenia (BACS), Working Alliance Inventory (WAI), and General Self-Efficacy (GSE). Linear regression analyses were adjusted for age, sex, cognition, and self-efficacy.
RESULTS: Results revealed significant associations between working alliance and fewer negative (β = -0.12; 95% CI, -0.19 to -0.04) and disorganized symptoms (β = -0.06; 95% CI, -0.11 to -0.01), and between working alliance and better social functioning (β = 1.45; 95% CI, 0.55 to 2.36). General self-efficacy mediated the effect of working alliance, explaining 14%-18% of the variance in associated outcomes. Global level of cognitive functioning, compliance, and self-efficacy influenced clinical and functional outcome more strongly than working alliance.
CONCLUSIONS: Better working alliance was weakly associated with fewer negative and disorganized symptoms and better social functioning. A strong working alliance may be a prerequisite for adherence to the specialized early intervention services treatment, providing the basis for positive treatment outcome. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00914238. © Copyright 2015 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25650684     DOI: 10.4088/JCP.13m08814

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

Review 1.  Common Factors in Community Mental Health Intervention: A Scoping Review.

Authors:  Sean A Kidd; Larry Davidson; Kwame McKenzie
Journal:  Community Ment Health J       Date:  2017-02-13

2.  Look Before You Leap: Representativeness of Those Completing Self-Reports in Early Psychosis Research.

Authors:  Srividya N Iyer; Sally Mustafa; Sherezad Abadi; Ridha Joober; Ashok Malla
Journal:  Can J Psychiatry       Date:  2019-09-26       Impact factor: 4.356

3.  Peer Support: a Human Factor to Enhance Engagement in Digital Health Behavior Change Interventions.

Authors:  Karen L Fortuna; Jessica M Brooks; Emre Umucu; Robert Walker; Phillip I Chow
Journal:  J Technol Behav Sci       Date:  2019-05-29

4.  Treatment engagement of individuals experiencing mental illness: review and update.

Authors:  Lisa B Dixon; Yael Holoshitz; Ilana Nossel
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

5.  OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial.

Authors:  Franco Mascayano; Iruma Bello; Howard Andrews; Diego Arancibia; Tamara Arratia; María Soledad Burrone; Sarah Conover; Kim Fader; Maria Jose Jorquera; Mauricio Gomez; Sergio Malverde; Gonzalo Martínez-Alés; Jorge Ramírez; Gabriel Reginatto; Alexandra Restrepo-Henao; Robert A Rosencheck; Sara Schilling; Thomas E Smith; Gonzalo Soto-Brandt; Eric Tapia; Tamara Tapia; Paola Velasco; Melanie M Wall; Lawrence H Yang; Leopoldo J Cabassa; Ezra Susser; Lisa Dixon; Rubén Alvarado
Journal:  Trials       Date:  2022-09-05       Impact factor: 2.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.